EHC (Encompass Health) GF Value : $81.50 (As of May. 01, 2025)

View and export this data going back to 1989. Start your Free Trial

What is Encompass Health GF Value?

As of today (2025-05-01), Encompass Health's share price is $116.69. Encompass Health's GF Value is $81.50. Therefore, Encompass Health's Price-to-GF-Value for today is 1.43. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Encompass Health is Significantly Overvalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Encompass Health (NYSE:EHC) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (1)
Possible Value Trap, Think Twice	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)	Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.

Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.

Encompass Health's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	116.69	/	81.50
	=	1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encompass Health GF Value Related Terms

Thank you for viewing the detailed overview of Encompass Health's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Encompass Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Encompass Health Corp (NYSE:EHC) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

HSOA:Germany HSOA:Germany

Address

9001 Liberty Parkway, Birmingham, AL, USA, 35242

Website

https://www.encompasshealth.com

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Executives

Andrew L Price	officer: Interim Chief Accting Officer	3660 GRANDVIEW PARKWAY, SUITE 200, BIRMINGHAM AL 35243
Douglas E Coltharp	officer: EVP, Chief Financial Officer	C/O UNDER ARMOUR, INC., 1020 HULL STREET, BALTIMORE MD 21230
Elissa Joy Charbonneau	officer: Chief Medical Officer	24 HAWTHORNE CIRCLE, YARMOUTH ME 04096
John Patrick Darby	officer: EVP, Gen Counsel & Secretary	3115 OVERHILL ROAD, BIRMINGHAM AL 35223
Greg D Carmichael	director
Mark J Tarr	officer: Executive VP Operations	C/O ENCOMPASS HEALTH CORPORATION, 9001 LIBERTY PARKWAY, BIRMINGHAM AL 35242
Kevin J. O'connor	director	13995 PASTEUR BOULEVARD, PALM BEACH GARDENS FL 33418
Terrance Williams	director	7184 BIDDICK, NEW ALBANY OH 43054
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Barbara Ann Jacobsmeyer	officer: EVP, Operations	2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Donald L Correll	director	C/O INTERCHANGE FINANCIAL SERVICES CORP, PARK 80 W PLAZA TWO, SADDLE BROOK NJ 07663
Anthony April Kaye Bullock	officer: CEO and President, Encompass	3606 PRINCETON AVENUE, DALLAS TX 75205
Higdon Leo I Jr	director	1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Patricia Anne Maryland	director	7342 HORIZON DRIVE, WEST PALM BEACH FL 33412
Yvonne M Curl	director	C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206